ABBA Lab

Advanced Biomaterials for Biomedical Applications Lab

Journal

Ta ion implanted nanoridge-platform for enhanced vascular responses
Year
2019
Author
Tae-Sik Jang, Jae Hwan Lee, Sungwon Kim, Cheonil Park, Juha Song, Hwan Jun Jae, Hyoun-Ee Kim, Jin Wook Chung, Hyun-Do Jung*
Publication date
2019/12
Journal
Biomaterials
Vol
223
Page
119461
File
1-s2.0-S0142961219305605-main 2.pdf (4.7M) 6회 다운로드 DATE : 2020-11-10 11:52:11
Bare metal stents are commonly used in interventional cardiology; they provide successful treatment because of their excellent mechanical properties, expandability ratios, and flexibility. However, their insufficient vascular affinity can induce the development of neointimal hyperplasia following arterial injury and subsequent smooth muscle cell overgrowth in the lumen of a stented vessel. Nanoengineering of the bare metal stent surface is a valuable strategy for eliciting favorable vascular responses. In this study, we introduce a target-ion-induced plasma sputtering (TIPS) technique to fabricate a platform with a favorable endothelial environment. This technique enables the simple single-step production of a Ta-implanted nanoridged surface on a stent with a complex 3D geometry that shows a clear tendency to become oriented parallel to the direction of blood flow. Moreover, the nanoridges developed show good structural integrity and mechanical stability, resulting in apparently stable morphologies under high strain rates. In vitro cellular responses to the Co–Cr, such as endothelialization, platelet activation, and blood coagulation, are considerably altered after TIPS treatment; endothelium formation is rapid and surface thrombogenicity is low. An in vivo rabbit iliac artery model is used to confirm that the nanoridged surface facilitates rapid re-endothelialization and limits the formation of neointima compared to the bare stent. These results indicate that the Ta ion implanted nanoridge platform fabricated using the TIPS technique has immense potential as a solution for in-stent restenosis and ensuring the long-term patency of bare metal stents.